Top Markets
Coin of the day
ABVC BioPharma, Inc. ABVC BioPharma, Inc.

ABVC BioPharma, Inc.

ABVC
Rank in Stocks #28867
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on... ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.
Share Price
$0.9201
Market Cap
$23.92M
Change (1 day)
6.23%
Change (1 year)
-67.72%
Country
US
Trade ABVC BioPharma, Inc. (ABVC)

Category

Stock price history for ABVC BioPharma, Inc. (ABVC)
Highest end of day price: $0.94 on 2026-08-01

Lowest end of day price: $455.54K on 2004-11-01
Stock price history of ABVC BioPharma, Inc. from 2004 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -15.73%
2025 331.39%
2024 -56.69%
2023 -82.53%
2022 -79.50%
2021 -27.15%
2020 -18.60%
2019 -79.88%
2018 -21.05%
2017 0.00%
2016 -74.88%
2015 -42.11%
2014 -17.94%
2013 -48.16%
2012 -81.81%
2011 -12.18%
2010 -91.16%
2009 -58.61%
2008 -66.11%
2007 -5.25%
2006 160.11%
2005 191.95%
2004 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$542.79 38.90%
US
$1.02K 55.75%
NL
$142.08 409.08%
US
$117.42 -19.34%
AU
$753.28 8.59%
CH